Copyright
©The Author(s) 2022.
World J Hepatol. Jul 27, 2022; 14(7): 1470-1479
Published online Jul 27, 2022. doi: 10.4254/wjh.v14.i7.1470
Published online Jul 27, 2022. doi: 10.4254/wjh.v14.i7.1470
Predictor | P value | Hazard ratio |
Age | 0.001 | 1.08 (95%CI: 1.04-1.15) |
Vaccination | 0.027 | 0.09 (95%CI: 0.01-0.76) |
Child-Turcotte-Pugh class | 0.001 | 4.13 (95%CI: 1.82-9.35) |
Diabetes mellitus | 0.363 | |
Ischemic heart disease | 0.595 | |
Cancer | 0.751 | |
Asthma | 0.342 | |
Chronic obstructive pulmonary disease | 0.851 |
- Citation: Ivashkin V, Ismailova A, Dmitrieva K, Maslennikov R, Zharkova M, Aliev S, Bakhitov V, Marcinkevich V. Efficacy and safety of COVID-19 vaccination in patients with cirrhosis. World J Hepatol 2022; 14(7): 1470-1479
- URL: https://www.wjgnet.com/1948-5182/full/v14/i7/1470.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i7.1470